Key facts
- Protein Dynamic Solutions’s last known valuation is $2.9M (Nov 2025).
- It has raised $10.1M across 3 recorded rounds; the latest was Seed Round ($610K) in Jan 2020.
- Notable investors include US National Science Foundation, X-Square Capital, Antoine de Marsily, Aurdoro PR Holdings, Broadside — 15 tracked in total.
- Protein Dynamic Solutions has filed 3 Form Ds with the SEC since 2018, most recently Feb 2020 ($610K sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Protein Dynamic Solutions
Funding rounds
3 roundsAbout Protein Dynamic Solutions
Developer of a high-throughput analytical platform designed to offer critical quality attribute (CQA) analysis. The company's platform uses hyperspectral imaging and advanced signal processing to evaluate protein stability, aggregation, identity, and binding interactions, enabling biopharmaceutical companies to reduce release testing, analysis times, and product inventory.
- Sector
- Healthcare
- HQ
- Wakefield, MA, United States
- Founded
- 2011
- Employees
- 9
- Website
- pdsbio.com/
- Ownership
- Privately Held (backing)
Protein Dynamic Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Protein Dynamic Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Protein Dynamic Solutions in its N-PORT filings yet. We sweep new filings monthly.